Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma

BACKGROUND: The objective of this study is to indicate the role of urokinase plasminogen activator receptor (uPAR), soluble uPAR (suPAR), and β1 integrin in tumor growth and invasion of lymph nodes from Hodgkin's lymphoma (HL) patients. MATERIALS AND METHODS: In this study, 25 lymph nodes from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouhpayeh, Shirin, Andalib, Alireza, Gharagozloo, Marjan, Sanei, Mohammad Hossein, Esmaeil, Nafiseh, Maracy, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590394/
https://www.ncbi.nlm.nih.gov/pubmed/28904936
http://dx.doi.org/10.4103/2277-9175.213668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590394/
https://www.ncbi.nlm.nih.gov/pubmed/28904936
http://dx.doi.org/10.4103/2277-9175.213668

Ejemplares similares